Researchers: Mina Wang, Yan Tan, Yifan Shi, Xu Wang, Zehuan Liao, Peng Wei
Sarcopenic obesity and diabetes are two increasing health problems worldwide, which both share many common risk factors, such as aging, and general obesity. The pathogenesis of sarcopenic obesity includes aging, physical inactivity, malnutrition, low-grade inflammation, insulin resistance, and hormonal changes. Nevertheless, there are two major reasons to cause diabetes: impaired insulin secretion and impaired insulin action. Furthermore, the individual diagnosis of obesity and sarcopenia should be combined to adequately define sarcopenic obesity. Also, the diagnosis of diabetes includes fasting plasma glucose test (FPG), 2-h oral glucose tolerance test (OGTT), glycated hemoglobin (A1C), and random plasma glucose coupled with symptoms. Healthy diet and physical activity are beneficial to both sarcopenic obesity and diabetes, but there are only recommended drugs for diabetes. This review consolidates and discusses the latest research in pathogenesis, diagnosis, and treatments of diabetes and sarcopenic obesity.
References
- Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives.
- Exercise and Nutrition Strategies to Counteract Sarcopenic Obesity.
- Sarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons—a narrative review.
- Prevention and Treatment of Sarcopenic Obesity in Women.
- Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group.
- Sarcopenic Obesity: Time to Meet the Challenge.
- Beneficial effects of exercise on age-related mitochondrial dysfunction and oxidative stress in skeletal muscle.
- Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.